Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1395436

C=CCc1cccc[n+]1Cc1ccccc1.[Cl-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 3/20 0.34
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 2/20 0.35
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2732035 0.98 CYP2D6 (0.41) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL11867934 0.85 GABRA1 (0.38) KDM4EALDH1A1HPGDCYP2D6CYP2C19
Hydrochloric Acid SCHEMBL28319945 0.80 KDM4E (0.44) KDM4EACHEBCHE
Hydrochloric Acid SCHEMBL11725090 0.78 KDM4E (0.45) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL1038673 0.78 KDM4E (0.41) KDM4EACHEBCHE
Bromide SCHEMBL14811730 0.77 KDM4E (0.40) KDM4ERAB9ASMN1; SMN2NPC1ACHE
Hydrochloric Acid SCHEMBL6892436 0.75 HDAC8 (0.46) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL3479356 0.73 SMN1; SMN2 (0.40) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
Bromide SCHEMBL11692702 0.73 TP53 (0.48) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL31304100 0.73 HDAC8 (0.47) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240218234-A1 PARAFFIN WAX DISPERSANT CHAMPIONX LLC 2024-07-04 US disclosed
WO-2024137469-A2 PARAFFIN WAX DISPERSANT CHAMPIONX LLC (US) 2024-06-27 WO disclosed
US-20240199955-A1 CORROSION INHIBITOR HAVING SILICA NANOPARTICLES CHAMPIONX LLC 2024-06-20 US disclosed
WO-2024124129-A1 CORROSION INHIBITOR HAVING SILICA NANOPARTICLES CHAMPIONX LLC (US) 2024-06-13 WO disclosed
EP-4381024-A1 POLYAMINE-POLYESTERS AS CORROSION INHIBITION Ecolab USA, Inc. (US) 2024-06-12 EP disclosed
US-11993744-B2 Solid paraffin inhibitor and corrosion inhibitor compositions CHAMPIONX USA INC. (US) 2024-05-28 US disclosed
US-20240117239-A1 COMBINATION PRODUCTS CONTAINING ANTI-AGGLOMERANT LOW DOSE HYDRATE INHIBITORS AND CORROSION INHIBITORS WITH IMPROVED CORROSION RESISTANCE CHAMPIONX LLC 2024-04-11 US disclosed
US-20240093090-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING THE SAME CHAMPIONX USA INC. (US) 2024-03-21 US disclosed
US-11932795-B2 Aromatic amine epoxide adducts for corrosion inhibition ECOLAB USA INC. (US) 2024-03-19 US disclosed
WO-2024054812-A2 COMBINATION PRODUCTS CONTAINING ANTI-AGGLOMERANT LOW DOSE HYDRATE INHIBITORS AND CORROSION INHIBITORS WITH IMPROVED CORROSION RESISTANCE CHAMPIONX LLC (US) 2024-03-14 WO disclosed
WO-2014210166-A1 EPOXIDE-BASED HYDROGEN SULFIDE SCAVENGERS ECOLAB USA INC. (US) 2014-12-31 WO disclosed
US-20140179568-A1 Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells BAKER HUGHES HOLDINGS LLC 2014-06-26 US disclosed
WO-2014089002-A1 PURIFYING AQUEOUS MIXTURES DERIVED FROM HYDROCARBON PRODUCTION PROCESSES PAN ASIAN CHEMICALS INC. (US) 2014-06-12 WO disclosed
WO-2013043491-A1 METHOD OF USING DITHIAZINES AND DERIVATIVES THEREOF IN THE TREATMENT OF WELLS BAKER HUGHES INCORPORATED (US) 2013-03-28 WO disclosed
US-8354361-B2 Method of using dithiazines and derivatives thereof in the treatment of wells BAKER HUGHES INCORPORATED (US) 2013-01-15 US disclosed
US-20120010110-A1 Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells BAKER HUGHES HOLDINGS LLC 2012-01-12 US disclosed
US-8022018-B2 Quaternized dithiazines and method of using same in treatment of wells BAKER HUGHES INCORPORATED (US) 2011-09-20 US disclosed
US-8022017-B2 Method of using dithiazine to inhibit corrosion BAKER HUGHES INCORPORATED (US) 2011-09-20 US disclosed
US-20110152131-A1 Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells BAKER HUGHES HOLDINGS LLC 2011-06-23 US disclosed
US-20110152137-A1 METHOD OF USING CORROSION INHIBITORS DERIVED FROM SPENT FLUIDS IN THE TREATMENT OF WELLS BAKER HUGHES HOLDINGS LLC 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010110-A1 Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells TST, GSS, NDUFS5 ACHE 4339/4885KDM4E 3641/4885ALDH1A1 2320/4885
US-20110152131-A1 Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells F12, ALOX5, FFAR3 ACHE 4605/4885KDM4E 3752/4885ALDH1A1 3427/4885
US-11932795-B2 Aromatic amine epoxide adducts for corrosion inhibition ITGA8, ADGRE5, CD59 ACHE 548/4885KDM4E 722/4885ALDH1A1 226/4885
US-11993744-B2 Solid paraffin inhibitor and corrosion inhibitor compositions TFPI, CTCF, ATR ACHE 277/4885KDM4E 131/4885ALDH1A1 3071/4885
US-20140179568-A1 Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells TST, GSS, NDUFS5 ACHE 4339/4885KDM4E 3641/4885ALDH1A1 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.